Company intelligence / Profile preview

Nucryst Pharmaceuticals

Wakefield, Massachusetts, United Statesbiospace.com ↗

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

Nucryst Pharmaceuticals developed and commercialized medical products using its proprietary atomically disordered nanocrystalline silver technology. Its main commercial success was the licensing of this technology to Smith & Nephew for the ACTICOAT™ wound dressing portfolio. The company also developed a topical cream containing NPI 32101 that received FDA clearance as a broad-spectrum antimicrobial barrier. Other pharmaceutical applications were in early development or discontinued by the time of asset acquisition by Smith & Nephew in December 2009[5][8].

Therapeutic areas: GastroenterologyDermatologyInfectious Diseases
Modalities: Nanocrystalline silver (as an antimicrobial agent)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Acticoat

Commercial

Indications: Advanced wound care, Infection

1 more asset in the full pipeline.

Request access →

Partnerships

Exclusive global license with Smith & Nephew plc for ACTICOAT™ advanced wound dressings since at least 2001; later full asset acquisition by Smith & Nephew plc in December 2009[5].

Beyond the preview

Go deeper on Nucryst Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucryst Pharmaceuticals.

Explore the full profile